pterygium

Search with Google Search with Bing
Information
Disease name
pterygium
Disease ID
DOID:0002116
Description
"A corneal disease that is characterized by a triangular tissue growth located_in cornea of the eye that is the result of collagen degeneration and fibrovascular proliferation." [url:https\://en.wikipedia.org/wiki/Pterygium_(conjunctiva)]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06200727 Active, not recruiting N/A Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases January 1, 2023 December 31, 2025
NCT05794204 Active, not recruiting Phase 2 RMP-A03 Ocular Suspension in Patients With Pterygium June 9, 2023 July 2024
NCT00320957 Completed Phase 3 Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital January 2006 December 2006
NCT00321035 Completed Phase 3 Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital December 2005
NCT00344201 Completed Phase 1 Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery November 2004 January 2008
NCT00346450 Completed Phase 3 Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation October 2001 December 2003
NCT00383825 Completed N/A ICG Angiography in Amniotic Membrane Graft and Conjunctival Autograft After Pterygium Excision January 2003 December 2004
NCT00391573 Completed N/A Polyglactin Sutures Versus Nylon Sutures for Suturing of Conjunctival Autograft in Pterygium Surgery: a Randomised Controlled Trial March 2005 June 2005
NCT00457223 Completed Phase 2/Phase 3 To Compare Fibrin Glue and Suture in Primary Pterygium Excision With Amniotic Membrane Transplantation April 2007 August 2007
NCT03049852 Completed Phase 2 Safety and Efficacy of CBT-001 Ophthalmic Solution in Patients With Pterygium April 15, 2017 April 30, 2018
NCT00320762 Completed Phase 3 Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital January 2006
NCT02866968 Completed N/A Clinical Outcomes of Femtosecond Laser-assisted Pterygium Surgery (FLAPS) July 6, 2016 June 2017
NCT05627947 Completed Phase 1 Comparison Between Topical Mitomycin C and Cyclosporine January 1, 2021 June 30, 2022
NCT00592176 Completed Phase 2 The Effect of Bevacizumab (Avastin) on Pterygium August 2007 March 2010
NCT05314673 Completed Phase 4 Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients January 1, 2019 January 1, 2021
NCT00713180 Completed N/A Determinants of Pterygium Occurrence and Recurrence in a Rural African Population August 2008 February 2012
NCT00768963 Completed Phase 1 Ranibizumab for the Inhibition of Neovascularization in Pterygia October 2008 January 2012
NCT00949728 Completed N/A Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia October 2006 July 2009
NCT01003613 Completed Phase 3 Evaluation of Tranilast to Treat Pterygium Before Excision February 2009 March 2012
NCT01024257 Completed Phase 3 Pterygium Treatment Using Single Beta-therapy as Adjuvant Treatment Compared to Conjunctival Autograft
NCT05164900 Completed N/A Manifestations of Ocular Irritation Following Pterygium Excision With Sutures Fixed Conjunctival Autograft July 1, 2020 October 1, 2021
NCT01083927 Completed N/A Rotational Narrow Strip Versus Full Conjunctival Graft in Pterygium Excision July 2007 July 2009
NCT01109056 Completed Phase 2 Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium June 2010 June 2011
NCT01115517 Completed Phase 2 Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery October 2010 July 2015
NCT01169909 Completed Phase 1 Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia August 2010 July 2014
NCT04403516 Completed Phase 4 Dextenza in Pterygium Surgery October 1, 2020 August 5, 2021
NCT01250353 Completed Phase 2 The Use of Natural Latex Biomembrane in Ocular Surface Reconstruction June 2006 July 2009
NCT04151017 Completed N/A Efficacy of Autologous Fibrin Glue in Pterygium June 12, 2019 December 1, 2020
NCT01311960 Completed Phase 3 Topical Bevacizumab for Preventing Recurrent Pterygium December 2010 April 2013
NCT04117386 Completed Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium January 1, 2020 June 15, 2020
NCT04022811 Completed Phase 4 Effect of Bromfenac on Pain Related to Pterygium Surgery October 2016 October 2017
NCT01686529 Completed Phase 1 Bevacizumab for Primary Pterygium Treatment March 2010 February 2012
NCT01736449 Completed Phase 4 Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management April 2011 April 2012
NCT02002338 Completed Different Surgical Techniques for Pterygium Surgery February 2013 October 2013
NCT02009072 Completed N/A Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery April 2010 November 2012
NCT03533244 Completed Phase 2 A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia October 11, 2018 October 25, 2019
NCT03521791 Completed Phase 4 Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. December 13, 2017 October 31, 2018
NCT03485001 Completed N/A Treatment of Primary Type I Pterygia With Argon Laser March 2014 October 2016
NCT02138019 Completed N/A The Application of Fibrin Glue (Tissucol Duo Quick) in External Eye Surgeries December 2009 December 2013
NCT03377348 Completed N/A Subconjunctival Injection of Triamcinolone Acetonide and Limited Peritomy During Pterygium Excision December 1, 2017 December 1, 2019
NCT02151305 Completed N/A Different Hemostasis According to the Anesthetic Agents August 2010 April 2012
NCT03204084 Completed Assessment of Low-temperature Plasma Surgery System in Pterygium With Fibrin Glue and Conjunctival Autografts August 2016 April 2017
NCT02342392 Completed Phase 2/Phase 3 Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study September 2012 September 2014
NCT06042296 Not yet recruiting Expression of CD44, PCNA and E-cadherin in Pterygium Tissue October 2023 January 2024
NCT06402643 Recruiting N/A Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium June 22, 2024 December 31, 2025
NCT05456425 Recruiting Phase 3 A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium June 30, 2022 December 31, 2026
NCT05978687 Recruiting Phase 4 The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision September 1, 2023 December 31, 2024
NCT02116062 Terminated N/A Robotic Surgery of the Ocular Surface June 2014 April 2018
NCT01068496 Terminated Risk Factors and Biomarkers Associated With Recurrence After Excision of Primary Pterygium March 2010 December 2014
NCT03217500 Unknown status N/A Corneal Epithelial Autograft for Pterygium July 20, 2017 December 30, 2019
NCT03301974 Unknown status N/A A Comparison Between Surgical Techniques for Securing Conjunctival Autografting in Primary Pterygium Surgery February 24, 2019 January 2020
NCT03304366 Unknown status Corneal Changes With Pentacam Before and After Pterygium November 2017 January 2019
NCT03314389 Unknown status N/A The Corneal and Conjunctiva Sensation Before and After Pterygium Surgeries May 1, 2018 October 1, 2019
NCT02148016 Unknown status Phase 1/Phase 2 Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation December 2012 September 2014
NCT02102776 Unknown status N/A Intraoperative Mitomycin C, Amniotic Membrane Transplantation and Conjunctival Autograft for Primary Pterygium December 2015 December 2017
NCT02015000 Unknown status N/A Surgical Result of Pterygium Extended Removal Followed by Fibrin Glue Assisted Amniotic Membrane Transplantation November 2013 November 2014
NCT01387971 Unknown status Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders September 2009 August 2012
NCT01380678 Unknown status Phase 3 Intralesional Bevacizumab Injection on Primary Pterygium January 2009 December 2012
NCT01261455 Unknown status N/A Prospective Randomized Pilot Study Comparing Inferior Versus Superior Conjunctival Autografts for Primary Pterygia October 2010 October 2012
NCT01249235 Unknown status N/A Bandage Contact Lens and Oral Analgesics Versus Patching and Oral Analgesics for Pain Following Pterygium Surgery October 2010 October 2011
NCT04682054 Unknown status N/A Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics January 15, 2021 December 31, 2021
NCT04683159 Unknown status N/A Brimonidine Tartrate for Pterygium Surgery February 2021 September 2021
NCT05026307 Unknown status N/A Corneal Topographic Changes After Pterygium Surgery June 15, 2021 February 2022
NCT00704977 Unknown status N/A Alcohol 20% for Separation of Pterygium and Comparison of Different Wound Closure Methods June 2008 July 2010
NCT00326560 Unknown status Phase 3 Comparison of Glue With Sutures for Pterygium Surgery May 2006 September 2007
NCT00563667 Unknown status N/A Effect of Pterygium Excision on Intraocular Lens Power Calculation for Subsequent Cataract Operation December 2003 December 2004
NCT00563277 Unknown status N/A Surgical Treatment of Concurrent Cataract and Primary Pterygium October 2004 December 2006
NCT02911532 Unknown status N/A Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia October 1, 2016 April 1, 2018
NCT02321150 Unknown status N/A A Novel Technique for the Removal of Pterygiums December 2013 December 2014
NCT02641132 Unknown status Phase 4 Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count. September 2015 December 2016
NCT00478790 Unknown status Phase 3 Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital February 2007 October 2011
NCT02782260 Unknown status Phase 2 Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium July 2016 January 2018
NCT00155402 Withdrawn Phase 1 The Application of Fibrin Glue in Ocular Surface Diseases April 2005 March 2008
Disase is a (Disease Ontology)
DOID:10124
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0033999
Exact Synonym (Disease Ontology)
surfer's eye
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0001059
ICD10 preferred id (Insert disease from ICD10)
D0006040
ICD10 class code (Insert disease from ICD10)
H11.0
MeSH unique ID (MeSH (Medical Subject Headings))
D011625